MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

In newly released data, lenacapavir, administered via a twice-yearly injection, has shown remarkable effectiveness at ...

Dolutegravir is an HIV integrase strand transfer inhibitor ... compared with Department of Health and Human Services treatment guidelines preferred regimens and demonstrated noninferiority ...

Contrary to popular belief, HIV remains a serious public health concern in Canada. New HIV diagnoses rose by a startling 25% ...

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Efavirenz is an important drug for treating HIV infection, but it causes negative neuropsychiatric effects in roughly 50% of ...

Mayor Donna Deegan will sign the Paris Declaration, making Jacksonville an official Fast-Track City, during a ceremony in ...

Drugmaker Gilead has announced that its new, twice-a-year shot of lenacapavir reduced HIV infections by 96% in a Phase 3 clinical trial. The company wi ...

The Palm Springs AIDS Memorial has been nearly a decade in the making, with challenges in finding the right design. News ...